225 related articles for article (PubMed ID: 1322285)
1. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status.
De Goeij DC; Dijkstra H; Tilders FJ
Endocrinology; 1992 Aug; 131(2):847-53. PubMed ID: 1322285
[TBL] [Abstract][Full Text] [Related]
2. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats.
de Goeij DC; Kvetnansky R; Whitnall MH; Jezova D; Berkenbosch F; Tilders FJ
Neuroendocrinology; 1991 Feb; 53(2):150-9. PubMed ID: 1849619
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence.
Berkenbosch F; De Goeij DC; Tilders FJ
Endocrinology; 1989 Jul; 125(1):28-34. PubMed ID: 2544403
[TBL] [Abstract][Full Text] [Related]
4. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
Plotsky PM; Sawchenko PE
Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
[TBL] [Abstract][Full Text] [Related]
5. Short stressor induced long-lasting increases of vasopressin stores in hypothalamic corticotropin-releasing hormone (CRH) neurons in adult rats.
Schmidt ED; Binnekade R; Janszen AW; Tilders FJ
J Neuroendocrinol; 1996 Sep; 8(9):703-12. PubMed ID: 8877819
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
[TBL] [Abstract][Full Text] [Related]
7. Chronic stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia.
De Goeij DC; Binnekade R; Tilders FJ
Am J Physiol; 1992 Aug; 263(2 Pt 1):E394-9. PubMed ID: 1325125
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis.
Schmidt ED; Janszen AW; Wouterlood FG; Tilders FJ
J Neurosci; 1995 Nov; 15(11):7417-26. PubMed ID: 7472494
[TBL] [Abstract][Full Text] [Related]
9. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
Bruhn TO; Plotsky PM; Vale WW
Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.
Hashimoto K; Yunoki S; Kageyama J; Ohno N; Takahara J; Ofuji T
Neuroendocrinology; 1981 Feb; 32(2):87-91. PubMed ID: 6259547
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats.
Buwalda B; de Boer SF; Schmidt ED; Felszeghy K; Nyakas C; Sgoifo A; Van der Vegt BJ; Tilders FJ; Bohus B; Koolhaas JM
J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
13. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
14. Transient suppression of resting corticosterone levels induces sustained increase of AVP stores in hypothalamic CRH-neurons of rats.
Schmidt ED; Janszen AW; Binnekade R; Tilders FJ
J Neuroendocrinol; 1997 Jan; 9(1):69-77. PubMed ID: 9023740
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats.
Whitnall MH; Smyth D; Gainer H
Neuroendocrinology; 1987 May; 45(5):420-4. PubMed ID: 3295576
[TBL] [Abstract][Full Text] [Related]
16. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary.
Merali Z; Hayley S; Kent P; McIntosh J; Bédard T; Anisman H
Behav Brain Res; 2009 Mar; 198(1):105-12. PubMed ID: 19014976
[TBL] [Abstract][Full Text] [Related]
17. Patterns of adrenocorticotropin secretagog release with hypoglycemia, novelty, and restraint after colchicine blockade of axonal transport.
Romero LM; Plotsky PM; Sapolsky RM
Endocrinology; 1993 Jan; 132(1):199-204. PubMed ID: 7678213
[TBL] [Abstract][Full Text] [Related]
18. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
Wilson MA; Biscardi R; Smith MD; Wilson SP
J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488
[TBL] [Abstract][Full Text] [Related]
19. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
[TBL] [Abstract][Full Text] [Related]
20. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.
Tilders FJ; Berkenbosch F; Vermes I; Linton EA; Smelik PG
Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
